These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9303204

  • 21. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR.
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [Abstract] [Full Text] [Related]

  • 22. A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana.
    Aebischer T, Bennett CL, Pelizzola M, Vizzardelli C, Pavelka N, Urbano M, Capozzoli M, Luchini A, Ilg T, Granucci F, Blackburn CC, Ricciardi-Castagnoli P.
    Eur J Immunol; 2005 Feb; 35(2):476-86. PubMed ID: 15657947
    [Abstract] [Full Text] [Related]

  • 23. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
    Daneshvar H, Coombs GH, Hagan P, Phillips RS.
    J Infect Dis; 2003 May 15; 187(10):1662-8. PubMed ID: 12721947
    [Abstract] [Full Text] [Related]

  • 24. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA, Glaichenhaus N, Laman JD, Carlier Y.
    Infect Immun; 2001 Jan 15; 69(1):617-21. PubMed ID: 11119565
    [Abstract] [Full Text] [Related]

  • 25. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK.
    East Afr Med J; 2001 Feb 15; 78(2):90-2. PubMed ID: 11682953
    [Abstract] [Full Text] [Related]

  • 26. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells.
    Kima PE, Soong L, Chicharro C, Ruddle NH, McMahon-Pratt D.
    Eur J Immunol; 1996 Dec 15; 26(12):3163-9. PubMed ID: 8977318
    [Abstract] [Full Text] [Related]

  • 27. Factors influencing the host response to Leishmania mexicana.
    Pérez H.
    Ciba Found Symp; 1983 Dec 15; 99():157-73. PubMed ID: 6227462
    [Abstract] [Full Text] [Related]

  • 28. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
    Rosas LE, Barbi J, Lu B, Fujiwara Y, Gerard C, Sanders VM, Satoskar AR.
    Eur J Immunol; 2005 Feb 15; 35(2):515-23. PubMed ID: 15668916
    [Abstract] [Full Text] [Related]

  • 29. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ, Teixeira CR, Andrade BB, Barral-Netto M, Barral A.
    Trends Parasitol; 2006 Jan 15; 22(1):32-40. PubMed ID: 16310413
    [Abstract] [Full Text] [Related]

  • 30. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A, Bates PA, Chance ML, Taylor MJ.
    Parasit Vectors; 2016 Oct 06; 9(1):532. PubMed ID: 27716391
    [Abstract] [Full Text] [Related]

  • 31. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis.
    Weiss R, Scheiblhofer S, Thalhamer J, Bickert T, Richardt U, Fleischer B, Ritter U.
    Vaccine; 2007 Jan 02; 25(1):25-33. PubMed ID: 17064826
    [Abstract] [Full Text] [Related]

  • 32. Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells.
    Herath S, Kropf P, Müller I.
    Parasite Immunol; 2003 Jan 02; 25(11-12):559-67. PubMed ID: 15053777
    [Abstract] [Full Text] [Related]

  • 33. [Leishmaniasis: principles of the immune response and function of nitric oxide].
    Bogdan C.
    Berl Munch Tierarztl Wochenschr; 1998 Jan 02; 111(11-12):409-14. PubMed ID: 9880934
    [Abstract] [Full Text] [Related]

  • 34. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.
    Scott P, Artis D, Uzonna J, Zaph C.
    Immunol Rev; 2004 Oct 02; 201():318-38. PubMed ID: 15361250
    [Abstract] [Full Text] [Related]

  • 35. Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis.
    Moll H, Berberich C.
    Immunobiology; 2001 Dec 02; 204(5):659-66. PubMed ID: 11846231
    [Abstract] [Full Text] [Related]

  • 36. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
    Conrad SM, Strauss-Ayali D, Field AE, Mack M, Mosser DM.
    Infect Immun; 2007 Feb 02; 75(2):653-65. PubMed ID: 17088347
    [Abstract] [Full Text] [Related]

  • 37. In situ cytokines (IL-4, IL-10, IL-12, IFN-γ) and chemokines (MCP-1, MIP-1α) gene expression in human Leishmania (Leishmania) Mexicana infection.
    Valencia-Pacheco G, Loría-Cervera EN, Sosa-Bibiano EI, Canché-Pool EB, Vargas-Gonzalez A, Melby PC, Andrade-Narvaez FJ.
    Cytokine; 2014 Sep 02; 69(1):56-61. PubMed ID: 25022962
    [Abstract] [Full Text] [Related]

  • 38. Vaccination with Leishmania mexicana LPG induces PD-1 in CD8⁺ and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy.
    Martínez Salazar MB, Delgado Domínguez J, Silva Estrada J, González Bonilla C, Becker I.
    Vaccine; 2014 Mar 05; 32(11):1259-65. PubMed ID: 24462405
    [Abstract] [Full Text] [Related]

  • 39. Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses.
    Pereira WF, Ribeiro-Gomes FL, Guillermo LV, Vellozo NS, Montalvão F, Dosreis GA, Lopes MF.
    J Leukoc Biol; 2011 Dec 05; 90(6):1191-7. PubMed ID: 21934068
    [Abstract] [Full Text] [Related]

  • 40. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP, Panosian CB, Wyler DJ.
    J Immunol; 1984 Dec 05; 133(6):3351-7. PubMed ID: 6333458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.